General Practice · Belleview, FL
NPI
1306087713
Since 2009
Specialty
General Practice
Code 208D00000X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
10250 SE US Highway 441
Belleview, FL, 34420
Phone (352) 259-2159
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
989 services
Medicare patients, 2024
112
Average age 73
Drug cost, 2024
$2.1M
17,701 prescriptions
Company payments, 2025
$25.41
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Juan A de Jesus Kalil was code 99213 (office e&m - established), 242 times for 99 patients. In total Juan A de Jesus Kalil billed 989 services in 45 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 242 | 99 | $60.10 | $15K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 87 | 14 | $0.78 | $68.17 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 57 | 57 | $17.91 | $1,021 |
| 96372 Injection Administration | Office | 56 | 28 | $10.73 | $601 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 47 | 47 | $17.93 | $843 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 34 | 34 | $125.41 | $4,264 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 30 | 15 | $46.92 | $1,408 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 17 | 17 | $159.50 | $2,711 |
| 99214 Office E&M - Established | Office | 17 | 16 | $92.67 | $1,575 |
| 99203 Office E&M - New | Office | 16 | 16 | $54.22 | $867 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 13 | 11 | $214.50 | $2,788 |
| 93000 Electrocardiogram | Office | 13 | 13 | $7.66 | $99.63 |
| G0136 Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes | Office | 13 | 13 | $6.56 | $85.26 |
By year: 2022 $38K for 990 services; 2023 $47K for 1,020 services; 2024 $34K for 989 services.
Medicare prescription drug claims, 2024
In 2024, the drug Juan A de Jesus Kalil prescribed most often to Medicare patients was Atorvastatin Calcium, with 737 prescriptions and refills. In total Juan A de Jesus Kalil wrote 17,701 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 737 | 2,205 | 257 | $7,406 |
| Levothyroxine Sodium Generic | 715 | 2,079 | 231 | $9,031 |
| Omeprazole Generic | 583 | 1,614 | 201 | $8,782 |
| Losartan Potassium Generic | 546 | 1,613 | 192 | $3,867 |
| Lisinopril Generic | 490 | 1,424 | 174 | $2,877 |
| Amlodipine Besylate Generic | 469 | 1,314 | 164 | $2,371 |
| Alprazolam Generic | 466 | 480 | 87 | $1,971 |
| Metformin Hcl Generic | 433 | 1,218 | 150 | $2,296 |
| Gabapentin Generic | 418 | 1,125 | 160 | $12K |
| Rosuvastatin Calcium Generic | 404 | 1,109 | 147 | $5,237 |
| Furosemide Generic | 376 | 1,006 | 130 | $2,110 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 350 | 778 | 131 | $15K |
| Simvastatin Generic | 319 | 926 | 107 | $1,890 |
| Methylprednisolone Generic | 313 | 323 | 224 | $3,612 |
| Tamsulosin Hcl Generic | 261 | 761 | 100 | $3,423 |
Brand drugs: 2,492 claims; generic drugs: 15,033 claims; opioid claims: 221.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Juan A de Jesus Kalil $25.41 ($25.41 in general payments such as food, travel and fees) from 1 company. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $25.41.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $25.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.